Although spatial- and temporal-specific gene regulations are likely governed by a combination of transcriptional and epigenetic regulators, it is tempting to speculate potential utility of PARPis in cancers carrying epigenetic mutations (eg, DNMT, SETDB1, and PRC) that may lead to similar derepression of TEs. This evidence concerns the gene PPRC1 and cancer.